Who we are

With over 20 years of experience, Amy has a proven track record of driving value and competitive advantage for organisations across a diverse range of industries, including financial services, telecoms, retail, consulting, and technology. Her expertise in data and advanced analytics has been honed through a breadth of experience in both start-up and large corporates, as well as through her global perspective, having lived and worked in five countries across three continents.

Amy also brings a wealth of insights through her membership to a number of key industry associations and boards including the Bank of England and Financial Conduct Authorities AI Public, Private Forum, a Founding Editorial Board member of Springer’s Journal of AI & Ethics, and serving on the Data Board at MIT Sloan Management School Centre for Information Systems Research and Melbourne Business School Centre for Business Analytics. 

Amy is a champion for diversity and inclusion, a co-inventor and co-author of multiple Patents and Publications. She was awarded an Honorary Doctorate for her leadership and contributions in the field of data science, and named as one of the global top 100 innovators in data and analytics in 2021 and 2022. Amy has a Ph.D in Data Mining, a MSc in AI, a BSc in Computer Science and an MBA. She is also a Graduate member of the Australian Institute of Company Directors (GAICD).

Dr Jean O'Hara FRCPsych grew up in Hong Kong. She came to London to study medicine, and qualified as a doctor in 1983, and as a psychiatrist in 1988. Her work focussed on mental health and inequalities for people from marginalised communities especially those with intellectual disabilities, autism and BAME backgrounds.  Jean was clinical director at South London and the Maudsley NHS Foundation Trust and King's Health Partners Academic Health Sciences Centre (2008-2017) where she led an innovative service model bringing together forensic, autism, ADHD and intellectual disability community and inpatient services across South East London.

Jean has held national leadership roles in the Royal Society of Medicine, the Royal College of Psychiatrists and at NHS England where she was National Clinical Director before retiring to set up her executive coaching and consultancy business. She remains an honorary consultant at the Maudsley, Visiting Senior Lecturer at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, Trustee at the British Institute for Learning Disabilities, and an ambassador for Savvitas Global, supporting and encouraging women in entrepreneurial and leadership roles.

Peter Fonagy, PhD, FMedSci, FBA, FAcSS, OBE, Professor of Contemporary Psychoanalysis and Developmental Science and Head of the Division of Psychology and Language Sciences at UCL; Executive Clinical Director, Mental Health and Wellbeing Programme, UCLPartners; Chief Executive of The Anna Freud National Centre for Children and Families, and Senior Clinical Advisor on Children’s Mental Health, NHS England.

His clinical and research interests centre on issues of early attachment relationships, social cognition, borderline personality disorder and violence. A major focus of his contribution has been an innovative research-based psychodynamic therapeutic approach, mentalization-based treatment, which was developed in collaboration with a number of clinical sites in the UK and USA. He has published over 630 scientific papers, 280 chapters, and authored or co-authored 21 books.

He is a Fellow of the British Academy, the Academy of Medical Sciences, and the Academy of Social Sciences. He has received Lifetime Achievement Awards from the British Psychological Society, the International Society for the Study of Personality Disorder and in 2015 was the first UK recipient of the British Academy Wiley Prize for Outstanding Achievements in Psychology.

Uma Vaidyanathan, Ph.D., is a Senior Associate Director and Global Clinical Program Leader at Boehringer Ingelheim. She has a doctorate in Biological Psychology, and over a decade of experience in behavioral neuroscience and statistics, spanning academia, government, and industry. In her current role, she oversees the development of digital mental health products, and in particular, is responsible for devising and evaluating evidence for their efficacy and effectiveness.

Uma is honored to have served as a facilitator for the SNOMED international healthcare terminology’s Mental and Behavioral Health Clinical Reference Group, as a member of the Wellcome Trust’s Mental Health Priority Area’s Strategic Advisory Board, and NIMH’s precision psychiatry initiative called RDoC. Most recently, she was also a part of the Presidential Leadership Scholars program with the George W. Bush and Clinton Foundations.